Altered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-rat

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Rodriguez, Karl A ^a   Edrey, Yael H ^a   Osmulski, Pawel ^a   Gaczynska, Maria ^a   Buffenstein, Rochelle ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHYMOTRYPSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GEL ELECTROPHORESIS; HEALTH STATUS; LIFESPAN; LIVER PARENCHYMA; MOLE RAT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPECIES DIFFERENCE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; FEMALE; LIVER; METABOLISM;

ANIMALIA; BATHYERGIDAE; HETEROCEPHALUS GLABER; MUS; RODENTIA;

ANIMALS; BLOTTING, WESTERN; FEMALE; LIVER; MICE; MICE, INBRED C57BL; MOLE RATS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 84860431090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035890     Document Type: Article

References (65)

1. Edrey YH, Park TJ, Kang H, Biney A, Buffenstein R, (2011) Successful aging and sustained good health in the naked mole rat: a long-lived model for biogenrontology and biomedical research. ILAR J 52: 41-53.
2. Buffenstein R, (2008) Negligible senescence in the longest living rodent, the naked mole-rat: insights from a successfully aging species. J Comp Physiol B 178: 439-445.
3. deMagalhães JP, Costa J, Church GM, (2007) An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts. J Gerontol A Biol Sci Med Sci 62: 149-160.
4. Ikeno Y, Hubbard GB, Lee S, Richardson A, Strong R, et al. (2005) Housing density does not influence the longevity effect of calorie restriction. Journals of Gerontology Series a-Biological Sciences and Medical Sciences 60: 1510-1517.
5. Kim EB, Fang X, Fushan AA, Huang Z, Lobanov AV, et al. (2011) Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature 479: 223-227.
6. Yu C, Li Y, Holmes A, Szafranski K, Faulkes CG, et al. (2011) RNA sequencing reveals differential expression of mitochondrial and oxidation reduction genes in the long-lived naked mole-rat when compared to mice. PLoS One 6: e26729.
7. Andziak B, O'Connor TP, Qi WB, DeWaal EM, Pierce A, et al. (2006) High oxidative damage levels in the longest-living rodent, the naked mole-rat. Aging Cell 5: 463-471.
8. Pérez VI, Buffenstein R, Masamsetti V, Leonard S, Salmon AB, et al. (2009) Protein stability and resistance to oxidative stress are determinants of longevity in the longest-living rodent, the naked mole-rat. Proc Natl Acad Sci USA 106: 3059-3064.
9. Glickman MH, Ciechanover A, (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428.
10. Pickart CM, (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503-533.
11. Hanna J, Finley D, (2007) A proteasome for all occasions. FEBS Lett 581: 2854-2861.
12. Zwickl P, Seemuller E, Kapelari B, Baumeister W, (2001) The proteasome: a supramolecular assembly designed for controlled proteolysis. Adv Protein Chem 59: 187-222.
13. Jung T, Grune T, (2008) The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 60: 743-752.
14. Enenkel C, Lehmann A, Kloetzel PM, (1998) Subcellular distribution of proteasomes implicates a major location of protein degradation in the nuclear envelope- ER network in yeast. EMBO J 17: 6144-6154.
15. Wojcik C, DeMartino GN, (2003) Intracellular localization of the proteasome. Int J Biochem Cell Biol 35: 579-589.
16. Rodriguez KA, Gaczynska M, Osmulski PA, (2010) Molecular mechanisms of proteasome plasticity in aging. Mech Ageing Dev 131.
17. Funabiki H, Yamano H, Kumada K, Nagao K, Hunt T, et al. (1996) Cut2 proteolysis required for sister-chromatid seperation in fission yeast. Nature 381: 438-441.
18. Yanagida M, (2000) Cell cycle mechanisms of sister chromatid separation; roles of Cut1/separin and Cut2/securin. Genes Cells 5: 1-8.
19. Brooks CL, Gu W, (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171.
20. Groll M, Bajorek M, Köhler A, Moroder L, Rubin DM, et al. (2000) A gated channel into the proteasome core particle. Nat Struct Biol 7: 1062-1067.
21. Unno M, Mizushima T, Morimoto Y, Tomisugi Y, Tanaka K, et al. (2002) The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure 10: 609-618.
22. Kim HM, Yu Y, Cheng Y, (2011) Structure characterization of the 26S proteasome. Biochem Biophys Acta 1809: 67-79.
23. Arendt CS, Hochstrasser M, (1997) Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. Proc Natl Acad Sci USA 94: 7156-7161.
24. Bajorek M, Glickman MH, (2004) Keepers at the final gates: regulatory complexes and gating of the proteasome channel. Cell Mol Life Sci 61: 1579-1588.
25. Rechsteiner M, Hill CP, (2005) Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 15: 27-33.
26. Grune T, Jung T, Merker K, Davies KJ, (2004) Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol 36: 2519-2530.
27. Baugh JM, Viktorova EG, Pilipenko EV, (2009) Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J Mol Biol 386: 814-827.
28. Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, et al. (2010) The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 432: 585-594.
29. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, Kensler TW, (2007) Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23: 8786-8794.
30. Aki M, Shimbara N, Takashina M, Akiyama K, Kagawa S, et al. (1994) Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem 115: 257-269.
31. Kapahi P, Boulton ME, Kirkwood TB, (1999) Positive correlation between mammalian life span and cellular resistance to stress. Free Radic Biol Med 26: 495-500.
32. Ferrington DA, Hussong SA, Roehrich H, Kapphahn RJ, Kavanaugh SM, et al. (2008) Immunoproteasome responds to injury in the retina and brain. J Neurochem 106: 158-169.
33. Krüger E, Kuckelkorn U, Sijts A, Kloetzel PM, (2003) The components of the proteasome system and their role in MHC class I antigen processing. Rev Physiol Biochem Pharmacol 148: 81-104.
34. Noda C, Tanahashi N, Shimbara N, Hendil KB, Tanaka K, (2000) Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats. Biochem Biophys Res Commun 277: 348-354.
35. Rock KL, York IA, Saric T, Goldberg AL, (2002) Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol 80: 1-70.
36. Li J, Powell SR, Wang X, (2011) Enhancement of proteaosme function by PA28α overexpression protects against oxidative stress. FASEB J 25: 883-893.
37. Hussong SA, Kapphahn RJ, Phillips SL, Maldonado M, Ferrington DA, (2010) Immunoproteasome deficiency alters retinal proteasome's response to stress. J Neurochem 113: 1481-1490.
38. Dasuri K, Nguyen A, Zhang L, Fernandez-Kim S-O, Bruce-Keller AJ, et al. (2009) Comparison of Liver and Brain Proteasomes for Oxidative Stress Induced Inactivation: Influence of Aging and Dietary Restriction. Free Rad Res 43: 28-36.
39. Vasuri F, Capizzi E, Bellavista E, Mishto M, Santoro A, et al. (2010) Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis. Biochem Biophys Res Commun 397: 301-306.
40. Gaczynska M, Osmulski PA, (2005) Characterization of noncompetitive regulators of proteasome activity. Meth Enzymol 398: 425-438.
41. Rodgers KJ, Dean RT, (2003) Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates. Int J Biochem Cell Biol 35: 716-727.
42. Lam YA, Lawson TG, Velayutham M, Zweier JL, Pickart CM, (2002) A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 416: 763-767.
43. Tai HC, Besche H, Goldberg AL, Schuman EM, (2010) Characterization of the Brain 26S Proteasome and its Interacting Proteins. Front Mol Neurosci 3 doi:10.3389/fnmol.2010.00012.
44. Hendil KB, Welinder KG, Pedersen D, Uerkvitz W, Kristensen P, (1993) Subunit stoichiometry of human proteasomes. Enzyme Protein 47: 232-240.
45. Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E, et al. (2012) Complete subunit architecture of the proteasome regulatory particle. Nature 482: 186-191.
46. Kruegel U, Robison B, Dange T, Kahlert G, Delaney JR, et al. (2011) Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae. PLos Genet 7: e1002253.
47. Wang J, Robida-Stubbs S, Tullet JM, Rual JF, Vidal M, et al. (2010) RNAi screening implicates a SKN-1-dependent transcriptional response in stress resistance and longevity deriving from translation inhibition. PLos Genet 6: e1001048.
48. McColl G, Rogers AN, Alavez S, Hubbard AE, Melov S, et al. (2010) Insulin-like signaling determines survival during stress via posttranscriptional mechanisms in C. elegans. Cell Metab 12: 260-272.
49. Kaeberlein M, Kennedy BK, (2001) Hot topics in aging research: protein translation and TOR signaling, 2010. Aging Cell 10: 185-190.
50. Pacifici RE, Kono Y, Davies KJ, (1993) Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem 268: 15405-15411.
51. Dasuri K, Ebenezer PJ, Zhang Z, Fernandez-Kim S-O, Uranga RM, et al. (2010) Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: Implications for oxidative stress and insolubility of newly synthesized proteins. Free Rad Bio Med 49: 1290-1297.
52. Lewis KN, Mele J, Hayes JD, Buffenstein R, (2010) Nrf2, a guardian of healthspan and gatekeeper of species longevity. Int Comp Biol 50: 829-843.
53. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, et al. (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142: 613-624.
54. Dahlmann B, Ruppert T, Kuehn L, Merforth S, Kloetzel PM, (2000) Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol 303: 643-653.
55. Kloetzel P-M, (2001) Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2: 179-187.
56. Lattanzi L, Rozera C, Marescotti D, D'Agostino G, Santodonato L, et al. (2011) IFN-alpha boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity. Immunobiology 216: 537-547.
57. Hoffmann A, Levchenko A, Scott ML, Baltimore D, (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245.
58. Li N, Karin M, (1999) Is NF-kB the sensor of oxidative stress? FASEB J 13: 1137-1143.
59. Kaspar JW, Niture SK, Jaiswal AK, (2009) Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Rad Bio Med 47: 1304-1309.
60. Buffenstein R, (2005) The naked mole-rat; a new long-living model for human aging research. J Gerontol Biol Sci 60: 1369-1377.
61. Liang S, Mele J, Wu Y, Buffenstein R, Hornsby PJ, (2010) Resistance to experimental tumorigenesis in cells of a long-lived mammal, the naked mole-rat(Heterocephalus glaber). Aging Cell 9: 626-635.
62. Liu CW, Li X, Thompson D, Wooding K, Chang TI, et al. (2006) ATP Binding and ATP Hydrolysis Play Distinct Roles in the Function of 26S Proteasome. Molecular Cell 24: 39-50.
63. Cusimano A, Azzolina A, Iovanna JL, Bachvarov D, McCubrey JA, et al. (2010) Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle 9: 1399-1410.
64. Elasser S, Schmidt M, Finley D, (2005) Characterization of the proteasome using native gel electrophoresis. Meth Enzymol 398: 353-363.
65. Vernace VA, Arnaud L, Schmidt-Glenewinkel T, Figueiredo-Pereira ME, (2007) Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J 21: 2672-2682.